EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects

Faezeh Mahmoudi, Davod Jafari, Seyedeh Mona Mousavi Esfahani, Arshad Hoseini, Mahmood Barati, Neda Saraygord-Afshari

Molecular Biotechnology · 2025

DOI: 10.1007/s12033-024-01275-7 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Faezeh Mahmoudi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, 14496114535, Iran. Hauptthemen laut MEDLINE: SARS-CoV-2, Nucleic Acid Amplification Techniques, COVID-19, Molecular Diagnostic Techniques. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Iran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specific and reliable diagnostic methods are becoming increasingly essential to identify patients in light of the high transmission rate and the recent appearance of the new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For the specific detection of SARS-CoV-2, our quantitative reverse transcription loop-mediated isothermal amplification (RT-qLAMP) assay implementation demonstrates how flexible it can be with two readouts: visualized colorimetric and real-time fluorescence. Different factors were optimized to improve the reaction conditions, including temperature (60 °C), assay runtime (60 min), primers, MgSO4 (6 mM), dNTPs (1 mM), LAMP Buffer (1.2 mM Tris-HCl), KCl (50 mM), pH (8), and phenol red (10 mM) concentrations. Regarding analytical sensitivity, the colorimetric RT-LAMP method detected samples with Ct values up to 29, while the RT-qLAMP assay identified up to Ct = 31. RT-qLAMP was evaluated on 40 clinical samples (25 positives and 15 negatives) for viral RNA detection. All negative samples were found negative through fluorescent reading in RT-qLAMP and quantitative reverse transcription PCR (RT-qPCR) assays. Twenty-three clinically positive samples demonstrated a positive RT-qLAMP reaction (up to Ct ≤ 31) with 92% clinical sensitivity, 100% clinical specificity, 100% positive predictive value (PPV), 88.24% negative predictive values (NPV), and 95% accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Nucleic Acid Amplification TechniquesCOVID-19Molecular Diagnostic TechniquesCOVID-19 Nucleic Acid TestingHumansSensitivity and SpecificityRNA, ViralColorimetry

Stichwörter der Autor:innen

Diagnostic virologyRT-qLAMPRT-qPCRSARS-CoV-2

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, 14496114535, Iran.
  • Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, 14496114535, Iran. mahmood.barati@gmail.com.
  • Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, 14496114535, Iran. neda.s.afshari@gmail.com.

Förderung

  • Iran University of Medical Sciences

Zitieren

APA

Mahmoudi, F., Jafari, D., Esfahani, S. M. M., Hoseini, A., Barati, M., & Saraygord-Afshari, N. (2025). Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01275-7

Vancouver

Mahmoudi F, Jafari D, Esfahani SMM, Hoseini A, Barati M, Saraygord-Afshari N. Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01275-7

BibTeX
@article{Mahmoudi2025,
  author = {Mahmoudi, Faezeh and Jafari, Davod and Esfahani, Seyedeh Mona Mousavi and Hoseini, Arshad and Barati, Mahmood and Saraygord-Afshari, Neda},
  title = {Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects},
  journal = {Molecular Biotechnology},
  year = {2025},
  doi = {10.1007/s12033-024-01275-7}
}
Kostenlos starten →